Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 145 Results

Title
Intervention Indication Therapeutic Area Year Actions
Brigatinib for ALK-positive, locally advanced or metastatic, non-small cell lung cancer previously treated with alectinib or ceritinib Brigatinib (Alunbrig; AP26113) Non-small-cell lung cancer (NSCLC) Lung and Respiratory Cancer 2019 View  |  Download
Brexanolone for postpartum depression Brexanolone (SAGE-547; Zulresso) Postnatal depression Mental and Behavioural Health 2019 View  |  Download
Bimekizumab for moderate to severe chronic plaque psoriasis Bimekizumab (UCB4940) Plaque psoriasis Dermatology 2019 View  |  Download
BIIB092 for progressive supranuclear palsy Gosuranemab (BIIB092; BMS-986168; IPN007) Progressive supranuclear palsy (PSP) Neurology 2019 View  |  Download
Benralizumab in addition to mometasone furoate for severe nasal polyposis Benralizumab (Fasenra; MEDI563) , Mometasone Furoate Nasal polyps Ear Nose and Throat (ENT) 2019 View  |  Download
Belimumab for lupus nephritis Belimumab (Benlysta; Lymphostat-B) Lupus nephritis Immunology , Nephrology 2019 View  |  Download
Belantamab mafodotin for relapsed / refractory multiple myeloma – Fourth line Belantamab mafodotin (GSK2857916; anti-BCMA-ADC) Multiple myeloma (MM) Haematological Cancer and Lymphomas 2019 View  |  Download
BCX7353 for prevention of acute attacks of angioedema in hereditary angioedema BCX7353 (Berotralstat; ORLADEYO) Hereditary angioedema (HAE) Genetic Disorders , Immunology 2019 View  |  Download
Baricitinib for moderate to severe atopic dermatitis Baricitinib (LY3009104; Olumiant) , Corticosteroids Atopic dermatitis Dermatology 2019 View  |  Download
Axicabtagene ciloleucel for relapsed/refractory indolent non-Hodgkin lymphoma Axicabtagene Ciloleucel (Yescarta; KTE-C19) Non-Hodgkin lymphoma (NHL) Haematological Cancer and Lymphomas 2019 View  |  Download
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications